Gosset Bacterial Fimbriae Overview
Fimbriae (Type 1 and AAF) are bacterial surface appendages critical for specific adhesion to host intestinal mucosal cells, enabling colonization, biofilm formation, and pathogenesis. These structures are primarily composed of repeating protein subunits, capped by a specialized adhesin (FimH for Type 1 fimbriae; AafA for AAF), that binds with high specificity to glycoproteins (such as mannose residues and fibronectin) on host epithelial surfaces, particularly under the mechanical stresses present in the gastrointestinal tract fluid flow. Targeting fimbriae or their adhesins is a distinct anti-infective therapeutic strategy to prevent or attenuate mucosal infections caused by pathogens like E. coli and Salmonella.
Mechanism of Action
Competitive inhibition (D-mannose mimics host carbohydrate receptors, blocking FimH adhesin on fimbriae); Passive immune targeting (vaccines raise antibodies to fimbrial subunits); Disruption of biofilm formation
Biological Functions
Disease Associations
Safety Considerations
- Antigenic variation may limit vaccine efficacy
- Off-target effects in microbiota if broadly targeting fimbrial adherence
- Potential impact on commensal colonization
Interacting Drugs
Associated Biomarkers
| Biomarker |
|---|
| FimH subunit detection (Type 1 fimbriae) |
| AAF gene expression (EAEC) |
| Biofilm formation on colon tissue in infection studies |